<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.dynamic-med.com/feeds/latestcomments/journal?quantity=&amp;format=rss&amp;version=">
        <title>Dynamic Medicine - Latest Comments</title>
        <link>http://www.dynamic-med.com/comments</link>
        <description>The latest comments on all articles published by Dynamic Medicine</description>
        <dc:date>2008-06-09T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li resource="http://www.dynamic-med.com/content/7/1/6" />
                                <rdf:li resource="http://www.dynamic-med.com/content/2/1/5" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.dynamic-med.com/content/7/1/6/comments#300570">
        <title>More information on what exactly was measured in Reynolds (2004) would have been useful</title>
        <link>http://www.dynamic-med.com/content/7/1/6/comments#300570</link>
        <description>&lt;p&gt;An important part of this paper is the indirect cost estimates taken from Reynolds et al [1].  It would have been useful to have been given clear information on what was measured in that study.&lt;/p&gt;&lt;p&gt;The current paper says at one point: &quot;Indirect costs include transportation, work productivity losses, disability reimbursements, loss of leisure or duties at home, or services provided by family members, friends, or other informal care providers&quot;.  However what Reynolds measured was the loss of productivity.  It didn&apos;t not measure the cost of disability re-imbursements, for example.  &lt;/p&gt;&lt;p&gt;This would partly explain differences with some other figures.  For example, a report published by Sheffield Halham University in the UK in 2003 estimated the cost to the UK at 3.467 billion pounds Sterling.  It calculated the &quot;cost to the nation&quot; by adding together the figure for the lost taxes from people not working plus the cost of paying them disability payments.&lt;/p&gt;&lt;p&gt;There could be said to be pluses and minuses with either method of course.&lt;/p&gt;&lt;p&gt;Also, one other minor point: it might have been useful to point out that part of the reason there would be discrepancies between quoted studies is the effect of inflation.  For example, we are told &quot;Lloyd and Pender estimated an average cost of $9,436 per patient with ME/CFS, including about AU $2,000 per patient in direct medical costs&quot;.  But we are not told in the text that the Lloyd and Pender study was published in 1992 (perhaps the figure was increased due to inflation but this has not been made clear).&lt;/p&gt;&lt;p&gt;[1] Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc. 2004 Jun 21;2(1):4. &lt;/p&gt;&lt;p&gt;[2] Lloyd AR, Pender H. The economic impact of chronic fatigue syndrome. Med J Aust. 1992 Nov 2;157(9):599-601.&lt;/p&gt;</description>
                <dc:creator>Tom Kindlon</dc:creator>
                <dc:date>2008-06-09T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.dynamic-med.com/content/2/1/5/comments#53454">
        <title>Data Analysis Pitfalls</title>
        <link>http://www.dynamic-med.com/content/2/1/5/comments#53454</link>
        <description>&lt;p&gt;Only recently have I heard about this journal and it took me by surprise the excellent quality of the presented articles. I&amp;#8217;m writing this comment to try to contribute to increase this quality even more.&lt;/p&gt;&lt;p&gt;The authors of this paper made an extensive and, apparently, carefull work to compare two common field methods used in body composition analysis. However, some mistakes at data analysis jeopardize the presented conclusions.&lt;/p&gt;&lt;p&gt;The results showed significant differences only in some age/sex groups. To the total subject pool, there was no difference. Such results could lead to believe that one can use both methods interchangeably in some age/sex groups or with the total subject pool, and can&amp;#8217;t with other age/sex groups. But significant differences only show the existence of systematic differences between groups, telling us nothing about the random differences between methods. Additionally, using nine t-tests in a row requires some kind of correction (i.e., Bonferroni correction), since the type-I error probability becomes very high (close to 50%)[1].&lt;/p&gt;&lt;p&gt;In random error analysis, the authors selected the limits of agreement technique [2]. That was a great choice! However, the graph presented at figure 1 describes only the mean difference &#191; one standard deviation (SD), while Bland-Altman plots uses two SD, representing confidence intervals to 95% of the intermethods differences.&lt;/p&gt;&lt;p&gt;Surprisingly, the authors used Pearson correlation coefficient to evaluate agreement between methods, while the same work of Altman and Bland [2], cited in the article, exhaustively demonstrates the inadequacy of this coefficient in evaluating intermethod agreement.&lt;/p&gt;&lt;p&gt;Such problems in data analysis probably led to the conclusion that the results of leg-to-leg BIA were &amp;#8220;comparable to those obtained using skinfold&amp;#8221;. Indeed, analysis of figure 1 shows that differences in percentual body fat predicted by different methods present a variation of approximately &#191;10%, even if only one SD (&#191;68% of results) is used.  This is a considerable difference! If we use two SD, differences increase to values above 20%.&lt;/p&gt;&lt;p&gt;Based on the facts exposed, I recommend caution in substituting one method by the other, since the intermethod difference could be greater than the real percentual body fat. Since the authors do not use any &amp;#8220;gold standard&amp;#8221; method (i.e., hydrostatic weighting), it is not possible to choose the best method to use.&lt;/p&gt;&lt;p&gt;References&lt;/p&gt;&lt;p&gt;1. Shaffer JP: Modified sequentially rejective multiple test procedures. Journal American Statistical Association 1986, 81:826-831.&lt;/p&gt;&lt;p&gt;2. Altman DG and Bland JM: Measurement in medicine: The analysis of method comparison studies. Statistician 1983, 32:307-317.&lt;/p&gt;&lt;p&gt;Sandro Sperandei&lt;/p&gt;&lt;p&gt;Federal University of Rio de Janeiro&lt;/p&gt;&lt;p&gt;Program of Biomedical Engeneering (COPPE)&lt;/p&gt;&lt;p&gt;Rio de Janeiro/RJ - Brazil&lt;/p&gt;</description>
                <dc:creator>Sandro Sperandei</dc:creator>
                <dc:date>2004-08-14T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
